SlideShare a Scribd company logo
1 of 4
Download to read offline
Tech Mahindra
Weak Q1FY16 outlook, Expect ‘Slow & Steady’ recovery
June 29, 2015
Prabhudas Lilladher Pvt. Ltd. and/or its associates (the 'Firm') does and/or seeks to do business with companies covered in its research reports. As a result investors should be aware that
the Firm may have a conflict of interest that could affect the objectivity of the report. Investors should consider this report as only a single factor in making their investment decision.
Please refer to important disclosures and disclaimers at the end of the report
EventUpdate
Shashi Bhusan
shashibhusan@plindia.com
+91-22-66322300
Hussain Kagzi
hussainkagzi@plindia.com
+91-22-66322242
Rating BUY
Price Rs483
Target Price Rs640
Implied Upside 32.5%
Sensex 27,645
Nifty 8,318
(Prices as on June 29, 2015)
Trading data
Market Cap. (Rs bn) 464.4
Shares o/s (m) 960.8
3M Avg. Daily value (Rs m) 4127.6
Major shareholders
Promoters 36.74%
Foreign 38.11%
Domestic Inst. 11.42%
Public & Other 13.73%
Stock Performance
(%) 1M 6M 12M
Absolute (12.8) (25.3) (9.0)
Relative (12.2) (26.3) (19.2)
How we differ from Consensus
EPS (Rs) PL Cons. % Diff.
2016 27.4 33.5 -18.4
2017 33.9 41.1 -17.4
Price Performance (RIC:TEML.BO,BB:TECHM IN)
Source: Bloomberg
0
100
200
300
400
500
600
700
800
Jun-14
Aug-14
Oct-14
Dec-14
Feb-15
Apr-15
Jun-15
(Rs)
Tech Mahindra came out with an investor release highlighting the Q1FY16 and FY16
outlook. Management indicated marginal revenue decline with sustained pressure
on margin in Q1FY16. However, outlook for FY16 for Enterprise Business continues
to be optimistic. We continue to expect “Slow and Steady” improvement in the
underlying business. We expect softness in near term, but retain our “BUY” rating as
we continue to believe in their long-term structural growth outlook.
 Q1FY16 – Weak revenue and margin outlook: Tech Mahindra expects marginal
decline in revenue overall revenue due to drag from Communication business
and seasonality in IP revenue. Moreover, full integration impact of LCC and
SOFGEN, H-1B visa cost (100-125bp), and lower IP revenue would drag EBIDTA
margin. We expected ~US$18m contribution from LCC and SOFGEN during the
quarter. Nevertheless, we now expect ~0.5% QoQ decline in USD term revenue
with margin erosion of ~60bp in Q1FY16.
 Challenges in Communication business to persist; Enterprise a bright spot: In-
line with the concerns highlighted in our note (dated 27th
May), Management
expects subdued organic growth for FY16 in Communications business due to
delayed decision making. However, Enterprise business is expected to grow in-
line or above Industry average. We expect ~11% YoY revenue growth in USD
term in FY16. Moreover, we expect revenue momentum to pick-up in H2FY16.
 Focus on Margin improvement: TechM’s EBITDA Margin was impacted due to
multiple reasons 1) Integration of large acquisition like LCC and SOFGEN (both
had high single digit margin) 2) Wage cost 3) Visa Cost 4) Lower IP revenue.
However, we see some of these costs will get absorbed over the course of the
year (FY16). Moreover, favourable currency movement, utilization
improvement, and automation could provide tailwind for Margin in FY16. We
expect margins to bottom out in H1FY16 and show improvement from thereon.
 Outlook & Valuation – Retain “BUY” with a revised TP to Rs640: We expect
earnings to bottom in Q2FY16. We revise our estimates down for FY16/17, and
expect near term pressure on the stock price. Revised TP of Rs640 (from Rs710).
 :Key financials (Y/e March) 2014 2015 2016E 2017E
Revenues (Rs m) 188,314 226,213 259,544 299,779
Growth (%) 31.4 20.1 14.7 15.5
EBITDA (Rs m) 41,837 41,528 40,470 49,705
PAT (Rs m) 29,087 26,273 26,285 32,569
EPS (Rs) 31.1 27.3 27.4 33.9
Growth (%) (24.6) (12.2) — 23.9
Net DPS (Rs) 5.0 6.0 7.5 7.5
Profitability & Valuation 2014 2015 2016E 2017E
EBITDA margin (%) 22.2 18.4 15.6 16.6
RoE (%) 39.8 24.5 19.9 21.2
RoCE (%) 32.5 20.5 16.9 18.4
EV / sales (x) 2.2 2.0 1.7 1.4
EV / EBITDA (x) 10.0 10.8 11.0 8.7
PE (x) 15.5 17.7 17.7 14.3
P / BV (x) 4.9 3.8 3.3 2.8
Net dividend yield (%) 1.0 1.2 1.5 1.5
Source: Company Data; PL Research
June 29, 2015 2
Tech Mahindra
Exhibit 1: Revise our estimates for FY16/FY17 downward
New Old Revision Consensus Variance
FY16E FY17E FY16E FY17E FY16E FY17E FY16E FY17E FY16E FY17E
Revenue (US$ m) 4,087 4,758 4,305 5,012 -5.1% -5.1%
Revenue (Rs m) 259,544 299,779 264,745 303,202 -2.0% -1.1% 270,041 308,900 -3.9% -3.0%
EBITDA 40,470 49,705 44,446 52,292 -8.9% -4.9% 47,191 56,081 -14.2% -11.4%
EBITDA Margin 15.6% 16.6% 16.8% 17.2% -120 bps -67 bps 17.5% 18.2% -188 bps -157 bps
EPS 26.72 33.11 29.72 35.12 -10.1% -5.7% 33.54 41.06 -20.3% -19.4%
Target Price 640 710 -9.9% 634 0.9%
Source: Company Data, Bloomberg, PL Research
June 29, 2015 3
Tech Mahindra
Income Statement (Rs m)
Y/e March 2014 2015 2016E 2017E
Net Revenue 188,314 226,213 259,544 299,779
Raw Material Expenses 117,001 151,578 181,477 207,189
Gross Profit 71,313 74,635 78,067 92,590
Employee Cost — — — —
Other Expenses 29,476 33,107 37,596 42,885
EBITDA 41,837 41,528 40,470 49,705
Depr. & Amortization 5,222 6,114 7,057 8,009
Net Interest 798 299 498 498
Other Income 1,130 1,064 2,367 2,519
Profit before Tax 36,947 36,179 35,281 43,717
Total Tax 7,524 9,596 8,997 11,148
Profit after Tax 29,423 26,583 26,285 32,569
Ex-Od items / Min. Int. 2,736 312 — —
Adj. PAT 29,087 26,273 26,285 32,569
Avg. Shares O/S (m) 934.0 960.8 960.8 960.8
EPS (Rs.) 31.1 27.3 27.4 33.9
Cash Flow Abstract (Rs m)
Y/e March 2014 2015 2016E 2017E
C/F from Operations 15,929 23,165 22,847 32,806
C/F from Investing (4,637) (7,162) (10,382) (11,991)
C/F from Financing (8,749) (7,260) 2,431 (8,379)
Inc. / Dec. in Cash 2,543 8,743 14,896 12,436
Opening Cash 28,003 14,519 12,060 26,956
Closing Cash 27,797 12,060 26,956 39,392
FCFF (14,466) 5,850 12,465 20,815
FCFE (24,746) 12,072 12,465 20,815
Key Financial Metrics
Y/e March 2014 2015 2016E 2017E
Growth
Revenue (%) 31.4 20.1 14.7 15.5
EBITDA (%) 36.6 (0.7) (2.5) 22.8
PAT (%) 37.5 (9.7) — 23.9
EPS (%) (24.6) (12.2) — 23.9
Profitability
EBITDA Margin (%) 22.2 18.4 15.6 16.6
PAT Margin (%) 15.4 11.6 10.1 10.9
RoCE (%) 32.5 20.5 16.9 18.4
RoE (%) 39.8 24.5 19.9 21.2
Balance Sheet
Net Debt : Equity (0.4) (0.1) (0.1) (0.2)
Net Wrkng Cap. (days) 39 35 43 42
Valuation
PER (x) 15.5 17.7 17.7 14.3
P / B (x) 4.9 3.8 3.3 2.8
EV / EBITDA (x) 10.0 10.8 11.0 8.7
EV / Sales (x) 2.2 2.0 1.7 1.4
Earnings Quality
Eff. Tax Rate 20.4 26.5 25.5 25.5
Other Inc / PBT 3.1 2.9 6.7 5.8
Eff. Depr. Rate (%) 10.7 10.2 10.0 9.7
FCFE / PAT (85.1) 45.9 47.4 63.9
Source: Company Data, PL Research.
Balance Sheet Abstract (Rs m)
Y/e March 2014 2015 2016E 2017E
Shareholder's Funds 91,820 122,489 141,592 165,782
Total Debt 524 6,746 6,746 6,746
Other Liabilities 21,637 18,446 18,446 18,446
Total Liabilities 113,981 147,681 166,784 190,974
Net Fixed Assets 22,966 28,723 34,423 38,406
Goodwill 5,640 17,283 17,283 17,283
Investments 14,719 21,028 21,028 21,028
Net Current Assets 57,532 63,685 77,087 97,295
Cash & Equivalents 33,202 24,049 26,956 39,392
Other Current Assets 69,745 90,436 103,462 119,501
Current Liabilities 45,415 50,800 53,331 61,598
Other Assets 13,124 16,962 16,962 16,962
Total Assets 113,981 147,681 166,784 190,974
Quarterly Financials (Rs m)
Y/e March Q1FY15 Q2FY15 Q3FY15 Q4FY15
Net Revenue 51,215 54,879 57,517 61,168
EBITDA 9,284 10,973 11,601 9,286
% of revenue 18.1 20.0 20.2 15.2
Depr. & Amortization 1,492 1,425 1,441 1,721
Net Interest 41 41 38 177
Other Income 893 576 190 (653)
Profit before Tax 8,644 10,083 10,312 6,735
Total Tax 2,308 2,807 2,512 1,845
Profit after Tax 6,307 7,196 8,054 4,721
Adj. PAT 6,307 7,196 7,769 4,720
Key Operating Metrics
Y/e March 2014 2015 2016E 2017E
Volume (persons months) — — — —
Realization (US$ / Hr) — — — —
Currency (USDINR) 60 61 64 63
SW Devp. Cost (% of Sales) 62.1 67.0 69.9 69.1
SG&A (% of sales) 15.7 14.6 14.5 14.3
Revenue (US$ m) 3,098 3,686 4,087 4,758
EBITDA Margin Expansion/(Erosion) (bps) 84.4 (385.9) (276.5) 98.8
Tax Rate (%) 20 27 26 26
Source: Company Data, PL Research.
June 29, 2015 4
Tech Mahindra
Prabhudas Lilladher Pvt. Ltd.
3rd Floor, Sadhana House, 570, P. B. Marg, Worli, Mumbai-400 018, India
Tel: (91 22) 6632 2222 Fax: (91 22) 6632 2209
Rating Distribution of Research Coverage PL’s Recommendation Nomenclature
42.9%
39.8%
17.3%
0.0%
0%
10%
20%
30%
40%
50%
BUY Accumulate Reduce Sell
%ofTotalCoverage
BUY : Over 15% Outperformance to Sensex over 12-months
Accumulate : Outperformance to Sensex over 12-months
Reduce : Underperformance to Sensex over 12-months
Sell : Over 15% underperformance to Sensex over 12-months
Trading Buy : Over 10% absolute upside in 1-month
Trading Sell : Over 10% absolute decline in 1-month
Not Rated (NR) : No specific call on the stock
Under Review (UR) : Rating likely to change shortly
DISCLAIMER/DISCLOSURES
ANALYST CERTIFICATION
We/I, Mr. Shashi Bhusan (BTech (IIT), MBA (IIM)), Mr. Hussain Kagzi (BMS), Research Analysts, authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report
accurately reflect our views about the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this
report.
Terms & conditions and other disclosures:
Prabhudas Lilladher Pvt. Ltd, Mumbai, India (hereinafter referred to as “PL”) is engaged in the business of Stock Broking, Portfolio Manager, Depository Participant and distribution for third party financial products. PL is a
subsidiary of Prabhudas Lilladher Advisory Services Pvt Ltd. which has its various subsidiaries engaged in business of commodity broking, investment banking, financial services (margin funding) and distribution of third
party financial/other products, details in respect of which are available at www.plindia.com
This document has been prepared by the Research Division of PL and is meant for use by the recipient only as information and is not for circulation. This document is not to be reported or copied or made available to
others without prior permission of PL. It should not be considered or taken as an offer to sell or a solicitation to buy or sell any security.
The information contained in this report has been obtained from sources that are considered to be reliable. However, PL has not independently verified the accuracy or completeness of the same. Neither PL nor any of its
affiliates, its directors or its employees accepts any responsibility of whatsoever nature for the information, statements and opinion given, made available or expressed herein or for any omission therein.
Recipients of this report should be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The suitability or otherwise of any investments will depend
upon the recipient's particular circumstances and, in case of doubt, advice should be sought from an independent expert/advisor.
Either PL or its affiliates or its directors or its employees or its representatives or its clients or their relatives may have position(s), make market, act as principal or engage in transactions of securities of companies
referred to in this report and they may have used the research material prior to publication.
PL may from time to time solicit or perform investment banking or other services for any company mentioned in this document.
PL is in the process of applying for certificate of registration as Research Analyst under Securities and Exchange Board of India (Research Analysts) Regulations, 2014
PL submits that no material disciplinary action has been taken on us by any Regulatory Authority impacting Equity Research Analysis activities.
PL or its research analysts or its associates or his relatives do not have any financial interest in the subject company.
PL or its research analysts or its associates or his relatives do not have actual/beneficial ownership of one per cent or more securities of the subject company at the end of the month immediately preceding the date of
publication of the research report.
PL or its research analysts or its associates or his relatives do not have any material conflict of interest at the time of publication of the research report.
PL or its associates might have received compensation from the subject company in the past twelve months.
PL or its associates might have managed or co-managed public offering of securities for the subject company in the past twelve months or mandated by the subject company for any other assignment in the past twelve
months.
PL or its associates might have received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months.
PL or its associates might have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months
PL or its associates might have received any compensation or other benefits from the subject company or third party in connection with the research report.
PL encourages independence in research report preparation and strives to minimize conflict in preparation of research report. PL or its analysts did not receive any compensation or other benefits from the subject
Company or third party in connection with the preparation of the research report. PL or its Research Analysts do not have any material conflict of interest at the time of publication of this report.
It is confirmed that Mr. Shashi Bhusan (BTech (IIT), MBA (IIM)), Mr. Hussain Kagzi (BMS), Research Analysts of this report have not received any compensation from the companies mentioned in the report in the
preceding twelve months
Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions.
The Research analysts for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its or their securities, and no part of his
or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report.
The research analysts for this report has not served as an officer, director or employee of the subject company PL or its research analysts have not engaged in market making activity for the subject company
Our sales people, traders, and other professionals or affiliates may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein,
and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all o
the foregoing, among other things, may give rise to real or potential conflicts of interest.
PL and its associates, their directors and employees may (a) from time to time, have a long or short position in, and buy or sell the securities of the subject company or (b) be engaged in any other transaction involving
such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the subject company or act as an advisor or lender/borrower to the subject company or may have any
other potential conflict of interests with respect to any recommendation and other related information and opinions.
DISCLAIMER/DISCLOSURES (FOR US CLIENTS)
ANALYST CERTIFICATION
The research analysts, with respect to each issuer and its securities covered by them in this research report, certify that: All of the views expressed in this research report accurately reflect his or her or their personal
views about all of the issuers and their securities; and No part of his or her or their compensation was, is or will be directly related to the specific recommendation or views expressed in this research report
Terms & conditions and other disclosures:
This research report is a product of Prabhudas Lilladher Pvt. Ltd., which is the employer of the research analyst(s) who has prepared the research report. The research analyst(s) preparing the research report is/are
resident outside the United States (U.S.) and are not associated persons of any U.S. regulated broker-dealer and therefore the analyst(s) is/are not subject to supervision by a U.S. broker-dealer, and is/are not required to
satisfy the regulatory licensing requirements of FINRA or required to otherwise comply with U.S. rules or regulations regarding, among other things, communications with a subject company, public appearances and
trading securities held by a research analyst account.
This report is intended for distribution by Prabhudas Lilladher Pvt. Ltd. only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the U.S. Securities and Exchange Act, 1934 (the Exchange Act) and
interpretations thereof by U.S. Securities and Exchange Commission (SEC) in reliance on Rule 15a 6(a)(2). If the recipient of this report is not a Major Institutional Investor as specified above, then it should not act upon
this report and return the same to the sender. Further, this report may not be copied, duplicated and/or transmitted onward to any U.S. person, which is not the Major Institutional Investor.
In reliance on the exemption from registration provided by Rule 15a-6 of the Exchange Act and interpretations thereof by the SEC in order to conduct certain business with Major Institutional Investors, Prabhudas
Lilladher Pvt. Ltd. has entered into an agreement with a U.S. registered broker-dealer, Marco Polo Securities Inc. ("Marco Polo").
Transactions in securities discussed in this research report should be effected through Marco Polo or another U.S. registered broker dealer.

More Related Content

What's hot

Ssrn id2379986
Ssrn id2379986Ssrn id2379986
Ssrn id2379986Iqbal Butt
 
Financial analysis of Sainsbury
Financial analysis of SainsburyFinancial analysis of Sainsbury
Financial analysis of Sainsburytechnakama
 
P&G financial analysis, spring 2014
P&G financial analysis, spring 2014P&G financial analysis, spring 2014
P&G financial analysis, spring 2014Ecaterina Barbus
 
Bapcor Annual Report Presentation
Bapcor Annual Report PresentationBapcor Annual Report Presentation
Bapcor Annual Report Presentationmjoass
 
Long-term Corporate Finance Project on GlaxoSmithKline Inc.
Long-term Corporate Finance Project on GlaxoSmithKline Inc.Long-term Corporate Finance Project on GlaxoSmithKline Inc.
Long-term Corporate Finance Project on GlaxoSmithKline Inc.nroopraj24
 
MindTree: Sharpened focus on growth, but rich valuation, accumulate - Prabhud...
MindTree: Sharpened focus on growth, but rich valuation, accumulate - Prabhud...MindTree: Sharpened focus on growth, but rich valuation, accumulate - Prabhud...
MindTree: Sharpened focus on growth, but rich valuation, accumulate - Prabhud...IndiaNotes.com
 
P&g presentation
P&g presentationP&g presentation
P&g presentationElisa Reyes
 
Fiscal Year Ended March 2016 Briefing on Financial Results
Fiscal Year Ended March 2016 Briefing on Financial ResultsFiscal Year Ended March 2016 Briefing on Financial Results
Fiscal Year Ended March 2016 Briefing on Financial ResultsRicohLease
 
Supplemental Schedules
Supplemental SchedulesSupplemental Schedules
Supplemental SchedulesMcgrawir
 
Volkswagen Financial ratio analysis for 2015 & 2016
Volkswagen Financial ratio analysis for 2015 & 2016Volkswagen Financial ratio analysis for 2015 & 2016
Volkswagen Financial ratio analysis for 2015 & 2016Priya Gujaran, MBA
 
Ashok Leyland Q1FY15: Losses narrowed down to Rs48 mn, hold
 Ashok Leyland Q1FY15: Losses narrowed down to Rs48 mn, hold Ashok Leyland Q1FY15: Losses narrowed down to Rs48 mn, hold
Ashok Leyland Q1FY15: Losses narrowed down to Rs48 mn, holdIndiaNotes.com
 
1 rubber factory ah authors
1 rubber factory ah authors 1 rubber factory ah authors
1 rubber factory ah authors HariharanAmutha1
 
Second Quarter of Fiscal Year Ending March 2016 Briefing on Financial Results
Second Quarter of Fiscal Year Ending March 2016 Briefing on Financial ResultsSecond Quarter of Fiscal Year Ending March 2016 Briefing on Financial Results
Second Quarter of Fiscal Year Ending March 2016 Briefing on Financial ResultsRicohLease
 
Bajaj Finance Q1FY15: AUM growth remained strong at Rs269.4 bn, buy
Bajaj Finance Q1FY15: AUM growth remained strong at Rs269.4 bn, buyBajaj Finance Q1FY15: AUM growth remained strong at Rs269.4 bn, buy
Bajaj Finance Q1FY15: AUM growth remained strong at Rs269.4 bn, buyIndiaNotes.com
 
2014 H1 Results and Review Presentation
2014 H1 Results and Review Presentation2014 H1 Results and Review Presentation
2014 H1 Results and Review PresentationCompany Spotlight
 

What's hot (16)

Ssrn id2379986
Ssrn id2379986Ssrn id2379986
Ssrn id2379986
 
Fundamental analysis
Fundamental analysisFundamental analysis
Fundamental analysis
 
Financial analysis of Sainsbury
Financial analysis of SainsburyFinancial analysis of Sainsbury
Financial analysis of Sainsbury
 
P&G financial analysis, spring 2014
P&G financial analysis, spring 2014P&G financial analysis, spring 2014
P&G financial analysis, spring 2014
 
Bapcor Annual Report Presentation
Bapcor Annual Report PresentationBapcor Annual Report Presentation
Bapcor Annual Report Presentation
 
Long-term Corporate Finance Project on GlaxoSmithKline Inc.
Long-term Corporate Finance Project on GlaxoSmithKline Inc.Long-term Corporate Finance Project on GlaxoSmithKline Inc.
Long-term Corporate Finance Project on GlaxoSmithKline Inc.
 
MindTree: Sharpened focus on growth, but rich valuation, accumulate - Prabhud...
MindTree: Sharpened focus on growth, but rich valuation, accumulate - Prabhud...MindTree: Sharpened focus on growth, but rich valuation, accumulate - Prabhud...
MindTree: Sharpened focus on growth, but rich valuation, accumulate - Prabhud...
 
P&g presentation
P&g presentationP&g presentation
P&g presentation
 
Fiscal Year Ended March 2016 Briefing on Financial Results
Fiscal Year Ended March 2016 Briefing on Financial ResultsFiscal Year Ended March 2016 Briefing on Financial Results
Fiscal Year Ended March 2016 Briefing on Financial Results
 
Supplemental Schedules
Supplemental SchedulesSupplemental Schedules
Supplemental Schedules
 
Volkswagen Financial ratio analysis for 2015 & 2016
Volkswagen Financial ratio analysis for 2015 & 2016Volkswagen Financial ratio analysis for 2015 & 2016
Volkswagen Financial ratio analysis for 2015 & 2016
 
Ashok Leyland Q1FY15: Losses narrowed down to Rs48 mn, hold
 Ashok Leyland Q1FY15: Losses narrowed down to Rs48 mn, hold Ashok Leyland Q1FY15: Losses narrowed down to Rs48 mn, hold
Ashok Leyland Q1FY15: Losses narrowed down to Rs48 mn, hold
 
1 rubber factory ah authors
1 rubber factory ah authors 1 rubber factory ah authors
1 rubber factory ah authors
 
Second Quarter of Fiscal Year Ending March 2016 Briefing on Financial Results
Second Quarter of Fiscal Year Ending March 2016 Briefing on Financial ResultsSecond Quarter of Fiscal Year Ending March 2016 Briefing on Financial Results
Second Quarter of Fiscal Year Ending March 2016 Briefing on Financial Results
 
Bajaj Finance Q1FY15: AUM growth remained strong at Rs269.4 bn, buy
Bajaj Finance Q1FY15: AUM growth remained strong at Rs269.4 bn, buyBajaj Finance Q1FY15: AUM growth remained strong at Rs269.4 bn, buy
Bajaj Finance Q1FY15: AUM growth remained strong at Rs269.4 bn, buy
 
2014 H1 Results and Review Presentation
2014 H1 Results and Review Presentation2014 H1 Results and Review Presentation
2014 H1 Results and Review Presentation
 

Similar to Prabhudas lilladher techmahindra_29june_2015

Cipla Q2 disappoints, gearing up for strong H2FY15E
Cipla Q2 disappoints, gearing up for strong H2FY15ECipla Q2 disappoints, gearing up for strong H2FY15E
Cipla Q2 disappoints, gearing up for strong H2FY15EIndiaNotes.com
 
Stock Tip: Buy this stock for a target of Rs270
Stock Tip: Buy this stock for a target of Rs270Stock Tip: Buy this stock for a target of Rs270
Stock Tip: Buy this stock for a target of Rs270IndiaNotes.com
 
Persistent Systems: Acquired RGen Solutions, Strengthening OPD presence
Persistent Systems: Acquired RGen Solutions, Strengthening OPD presencePersistent Systems: Acquired RGen Solutions, Strengthening OPD presence
Persistent Systems: Acquired RGen Solutions, Strengthening OPD presenceIndiaNotes.com
 
Intrasoft 1QFY18
Intrasoft 1QFY18Intrasoft 1QFY18
Intrasoft 1QFY18Mohit Jn
 
Zee 1QFY18
Zee 1QFY18Zee 1QFY18
Zee 1QFY18Mohit Jn
 
KSB Pumps Q3CY14 Result Update: Weak margin performance - Prabhudas Lilladher
KSB Pumps Q3CY14 Result Update: Weak margin performance - Prabhudas LilladherKSB Pumps Q3CY14 Result Update: Weak margin performance - Prabhudas Lilladher
KSB Pumps Q3CY14 Result Update: Weak margin performance - Prabhudas LilladherIndiaNotes.com
 
Mindtree 1QFY18
Mindtree 1QFY18Mindtree 1QFY18
Mindtree 1QFY18Mohit Jn
 
Dr. Reddy's 1FY15: Strong sales in key markets drive growth, margins
 Dr. Reddy's 1FY15: Strong sales in key markets drive growth, margins Dr. Reddy's 1FY15: Strong sales in key markets drive growth, margins
Dr. Reddy's 1FY15: Strong sales in key markets drive growth, marginsIndiaNotes.com
 
Mahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQ
Mahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQMahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQ
Mahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQIndiaNotes.com
 
Mastek 1QFY18
Mastek 1QFY18Mastek 1QFY18
Mastek 1QFY18Mohit Jn
 
Intellect 1QFY18
Intellect 1QFY18Intellect 1QFY18
Intellect 1QFY18Mohit Jn
 
ENIL 1QFY18
ENIL 1QFY18ENIL 1QFY18
ENIL 1QFY18Mohit Jn
 
Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15IndiaNotes.com
 
Voltas Visit Update: Muted near-term outlook - Prabhudas Lilladher
Voltas Visit Update: Muted near-term outlook - Prabhudas LilladherVoltas Visit Update: Muted near-term outlook - Prabhudas Lilladher
Voltas Visit Update: Muted near-term outlook - Prabhudas LilladherIndiaNotes.com
 
Cyient 1QFY18
Cyient 1QFY18Cyient 1QFY18
Cyient 1QFY18Mohit Jn
 
Hexaware Technologies Q1FY15: Margin troughed, sales uptick likely; accumulat...
Hexaware Technologies Q1FY15: Margin troughed, sales uptick likely; accumulat...Hexaware Technologies Q1FY15: Margin troughed, sales uptick likely; accumulat...
Hexaware Technologies Q1FY15: Margin troughed, sales uptick likely; accumulat...IndiaNotes.com
 
Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold
 Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold
Vaibhav Global Q1FY15: Outlook continues to remain positive; HoldIndiaNotes.com
 
LIC Housing Finance Q1FY15 performance in line with estimates; buy
 LIC Housing Finance Q1FY15 performance in line with estimates; buy LIC Housing Finance Q1FY15 performance in line with estimates; buy
LIC Housing Finance Q1FY15 performance in line with estimates; buyIndiaNotes.com
 
Setco Automotive Q1FY15: Revenue in-line; PAT below estimates - SPA Securities
Setco Automotive Q1FY15: Revenue in-line; PAT below estimates - SPA SecuritiesSetco Automotive Q1FY15: Revenue in-line; PAT below estimates - SPA Securities
Setco Automotive Q1FY15: Revenue in-line; PAT below estimates - SPA SecuritiesIndiaNotes.com
 

Similar to Prabhudas lilladher techmahindra_29june_2015 (20)

Cipla Q2 disappoints, gearing up for strong H2FY15E
Cipla Q2 disappoints, gearing up for strong H2FY15ECipla Q2 disappoints, gearing up for strong H2FY15E
Cipla Q2 disappoints, gearing up for strong H2FY15E
 
Stock Tip: Buy this stock for a target of Rs270
Stock Tip: Buy this stock for a target of Rs270Stock Tip: Buy this stock for a target of Rs270
Stock Tip: Buy this stock for a target of Rs270
 
Persistent Systems: Acquired RGen Solutions, Strengthening OPD presence
Persistent Systems: Acquired RGen Solutions, Strengthening OPD presencePersistent Systems: Acquired RGen Solutions, Strengthening OPD presence
Persistent Systems: Acquired RGen Solutions, Strengthening OPD presence
 
Intrasoft 1QFY18
Intrasoft 1QFY18Intrasoft 1QFY18
Intrasoft 1QFY18
 
Zee 1QFY18
Zee 1QFY18Zee 1QFY18
Zee 1QFY18
 
KSB Pumps Q3CY14 Result Update: Weak margin performance - Prabhudas Lilladher
KSB Pumps Q3CY14 Result Update: Weak margin performance - Prabhudas LilladherKSB Pumps Q3CY14 Result Update: Weak margin performance - Prabhudas Lilladher
KSB Pumps Q3CY14 Result Update: Weak margin performance - Prabhudas Lilladher
 
Mindtree 1QFY18
Mindtree 1QFY18Mindtree 1QFY18
Mindtree 1QFY18
 
Dr. Reddy's 1FY15: Strong sales in key markets drive growth, margins
 Dr. Reddy's 1FY15: Strong sales in key markets drive growth, margins Dr. Reddy's 1FY15: Strong sales in key markets drive growth, margins
Dr. Reddy's 1FY15: Strong sales in key markets drive growth, margins
 
Mahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQ
Mahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQMahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQ
Mahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQ
 
Mastek 1QFY18
Mastek 1QFY18Mastek 1QFY18
Mastek 1QFY18
 
Intellect 1QFY18
Intellect 1QFY18Intellect 1QFY18
Intellect 1QFY18
 
ENIL 1QFY18
ENIL 1QFY18ENIL 1QFY18
ENIL 1QFY18
 
Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15
 
Voltas Visit Update: Muted near-term outlook - Prabhudas Lilladher
Voltas Visit Update: Muted near-term outlook - Prabhudas LilladherVoltas Visit Update: Muted near-term outlook - Prabhudas Lilladher
Voltas Visit Update: Muted near-term outlook - Prabhudas Lilladher
 
Sonata IC
Sonata ICSonata IC
Sonata IC
 
Cyient 1QFY18
Cyient 1QFY18Cyient 1QFY18
Cyient 1QFY18
 
Hexaware Technologies Q1FY15: Margin troughed, sales uptick likely; accumulat...
Hexaware Technologies Q1FY15: Margin troughed, sales uptick likely; accumulat...Hexaware Technologies Q1FY15: Margin troughed, sales uptick likely; accumulat...
Hexaware Technologies Q1FY15: Margin troughed, sales uptick likely; accumulat...
 
Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold
 Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold
Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold
 
LIC Housing Finance Q1FY15 performance in line with estimates; buy
 LIC Housing Finance Q1FY15 performance in line with estimates; buy LIC Housing Finance Q1FY15 performance in line with estimates; buy
LIC Housing Finance Q1FY15 performance in line with estimates; buy
 
Setco Automotive Q1FY15: Revenue in-line; PAT below estimates - SPA Securities
Setco Automotive Q1FY15: Revenue in-line; PAT below estimates - SPA SecuritiesSetco Automotive Q1FY15: Revenue in-line; PAT below estimates - SPA Securities
Setco Automotive Q1FY15: Revenue in-line; PAT below estimates - SPA Securities
 

More from IndiaNotes.com

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15IndiaNotes.com
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaIndiaNotes.com
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaIndiaNotes.com
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesIndiaNotes.com
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoIndiaNotes.com
 
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityApollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityIndiaNotes.com
 
Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16IndiaNotes.com
 
Cummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtCummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtIndiaNotes.com
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...IndiaNotes.com
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...IndiaNotes.com
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CAREIndiaNotes.com
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...IndiaNotes.com
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16EIndiaNotes.com
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...IndiaNotes.com
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyIndiaNotes.com
 
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndiaNotes.com
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyIndiaNotes.com
 
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetTorrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetIndiaNotes.com
 

More from IndiaNotes.com (20)

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
 
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityApollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
 
Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16
 
Cummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtCummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debt
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARE
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16E
 
Nirmal lupin 06_aug15
Nirmal lupin 06_aug15Nirmal lupin 06_aug15
Nirmal lupin 06_aug15
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, Buy
 
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
 
Fce thermax 31_jul15
Fce thermax 31_jul15Fce thermax 31_jul15
Fce thermax 31_jul15
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
 
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetTorrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
 

Prabhudas lilladher techmahindra_29june_2015

  • 1. Tech Mahindra Weak Q1FY16 outlook, Expect ‘Slow & Steady’ recovery June 29, 2015 Prabhudas Lilladher Pvt. Ltd. and/or its associates (the 'Firm') does and/or seeks to do business with companies covered in its research reports. As a result investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of the report. Investors should consider this report as only a single factor in making their investment decision. Please refer to important disclosures and disclaimers at the end of the report EventUpdate Shashi Bhusan shashibhusan@plindia.com +91-22-66322300 Hussain Kagzi hussainkagzi@plindia.com +91-22-66322242 Rating BUY Price Rs483 Target Price Rs640 Implied Upside 32.5% Sensex 27,645 Nifty 8,318 (Prices as on June 29, 2015) Trading data Market Cap. (Rs bn) 464.4 Shares o/s (m) 960.8 3M Avg. Daily value (Rs m) 4127.6 Major shareholders Promoters 36.74% Foreign 38.11% Domestic Inst. 11.42% Public & Other 13.73% Stock Performance (%) 1M 6M 12M Absolute (12.8) (25.3) (9.0) Relative (12.2) (26.3) (19.2) How we differ from Consensus EPS (Rs) PL Cons. % Diff. 2016 27.4 33.5 -18.4 2017 33.9 41.1 -17.4 Price Performance (RIC:TEML.BO,BB:TECHM IN) Source: Bloomberg 0 100 200 300 400 500 600 700 800 Jun-14 Aug-14 Oct-14 Dec-14 Feb-15 Apr-15 Jun-15 (Rs) Tech Mahindra came out with an investor release highlighting the Q1FY16 and FY16 outlook. Management indicated marginal revenue decline with sustained pressure on margin in Q1FY16. However, outlook for FY16 for Enterprise Business continues to be optimistic. We continue to expect “Slow and Steady” improvement in the underlying business. We expect softness in near term, but retain our “BUY” rating as we continue to believe in their long-term structural growth outlook.  Q1FY16 – Weak revenue and margin outlook: Tech Mahindra expects marginal decline in revenue overall revenue due to drag from Communication business and seasonality in IP revenue. Moreover, full integration impact of LCC and SOFGEN, H-1B visa cost (100-125bp), and lower IP revenue would drag EBIDTA margin. We expected ~US$18m contribution from LCC and SOFGEN during the quarter. Nevertheless, we now expect ~0.5% QoQ decline in USD term revenue with margin erosion of ~60bp in Q1FY16.  Challenges in Communication business to persist; Enterprise a bright spot: In- line with the concerns highlighted in our note (dated 27th May), Management expects subdued organic growth for FY16 in Communications business due to delayed decision making. However, Enterprise business is expected to grow in- line or above Industry average. We expect ~11% YoY revenue growth in USD term in FY16. Moreover, we expect revenue momentum to pick-up in H2FY16.  Focus on Margin improvement: TechM’s EBITDA Margin was impacted due to multiple reasons 1) Integration of large acquisition like LCC and SOFGEN (both had high single digit margin) 2) Wage cost 3) Visa Cost 4) Lower IP revenue. However, we see some of these costs will get absorbed over the course of the year (FY16). Moreover, favourable currency movement, utilization improvement, and automation could provide tailwind for Margin in FY16. We expect margins to bottom out in H1FY16 and show improvement from thereon.  Outlook & Valuation – Retain “BUY” with a revised TP to Rs640: We expect earnings to bottom in Q2FY16. We revise our estimates down for FY16/17, and expect near term pressure on the stock price. Revised TP of Rs640 (from Rs710).  :Key financials (Y/e March) 2014 2015 2016E 2017E Revenues (Rs m) 188,314 226,213 259,544 299,779 Growth (%) 31.4 20.1 14.7 15.5 EBITDA (Rs m) 41,837 41,528 40,470 49,705 PAT (Rs m) 29,087 26,273 26,285 32,569 EPS (Rs) 31.1 27.3 27.4 33.9 Growth (%) (24.6) (12.2) — 23.9 Net DPS (Rs) 5.0 6.0 7.5 7.5 Profitability & Valuation 2014 2015 2016E 2017E EBITDA margin (%) 22.2 18.4 15.6 16.6 RoE (%) 39.8 24.5 19.9 21.2 RoCE (%) 32.5 20.5 16.9 18.4 EV / sales (x) 2.2 2.0 1.7 1.4 EV / EBITDA (x) 10.0 10.8 11.0 8.7 PE (x) 15.5 17.7 17.7 14.3 P / BV (x) 4.9 3.8 3.3 2.8 Net dividend yield (%) 1.0 1.2 1.5 1.5 Source: Company Data; PL Research
  • 2. June 29, 2015 2 Tech Mahindra Exhibit 1: Revise our estimates for FY16/FY17 downward New Old Revision Consensus Variance FY16E FY17E FY16E FY17E FY16E FY17E FY16E FY17E FY16E FY17E Revenue (US$ m) 4,087 4,758 4,305 5,012 -5.1% -5.1% Revenue (Rs m) 259,544 299,779 264,745 303,202 -2.0% -1.1% 270,041 308,900 -3.9% -3.0% EBITDA 40,470 49,705 44,446 52,292 -8.9% -4.9% 47,191 56,081 -14.2% -11.4% EBITDA Margin 15.6% 16.6% 16.8% 17.2% -120 bps -67 bps 17.5% 18.2% -188 bps -157 bps EPS 26.72 33.11 29.72 35.12 -10.1% -5.7% 33.54 41.06 -20.3% -19.4% Target Price 640 710 -9.9% 634 0.9% Source: Company Data, Bloomberg, PL Research
  • 3. June 29, 2015 3 Tech Mahindra Income Statement (Rs m) Y/e March 2014 2015 2016E 2017E Net Revenue 188,314 226,213 259,544 299,779 Raw Material Expenses 117,001 151,578 181,477 207,189 Gross Profit 71,313 74,635 78,067 92,590 Employee Cost — — — — Other Expenses 29,476 33,107 37,596 42,885 EBITDA 41,837 41,528 40,470 49,705 Depr. & Amortization 5,222 6,114 7,057 8,009 Net Interest 798 299 498 498 Other Income 1,130 1,064 2,367 2,519 Profit before Tax 36,947 36,179 35,281 43,717 Total Tax 7,524 9,596 8,997 11,148 Profit after Tax 29,423 26,583 26,285 32,569 Ex-Od items / Min. Int. 2,736 312 — — Adj. PAT 29,087 26,273 26,285 32,569 Avg. Shares O/S (m) 934.0 960.8 960.8 960.8 EPS (Rs.) 31.1 27.3 27.4 33.9 Cash Flow Abstract (Rs m) Y/e March 2014 2015 2016E 2017E C/F from Operations 15,929 23,165 22,847 32,806 C/F from Investing (4,637) (7,162) (10,382) (11,991) C/F from Financing (8,749) (7,260) 2,431 (8,379) Inc. / Dec. in Cash 2,543 8,743 14,896 12,436 Opening Cash 28,003 14,519 12,060 26,956 Closing Cash 27,797 12,060 26,956 39,392 FCFF (14,466) 5,850 12,465 20,815 FCFE (24,746) 12,072 12,465 20,815 Key Financial Metrics Y/e March 2014 2015 2016E 2017E Growth Revenue (%) 31.4 20.1 14.7 15.5 EBITDA (%) 36.6 (0.7) (2.5) 22.8 PAT (%) 37.5 (9.7) — 23.9 EPS (%) (24.6) (12.2) — 23.9 Profitability EBITDA Margin (%) 22.2 18.4 15.6 16.6 PAT Margin (%) 15.4 11.6 10.1 10.9 RoCE (%) 32.5 20.5 16.9 18.4 RoE (%) 39.8 24.5 19.9 21.2 Balance Sheet Net Debt : Equity (0.4) (0.1) (0.1) (0.2) Net Wrkng Cap. (days) 39 35 43 42 Valuation PER (x) 15.5 17.7 17.7 14.3 P / B (x) 4.9 3.8 3.3 2.8 EV / EBITDA (x) 10.0 10.8 11.0 8.7 EV / Sales (x) 2.2 2.0 1.7 1.4 Earnings Quality Eff. Tax Rate 20.4 26.5 25.5 25.5 Other Inc / PBT 3.1 2.9 6.7 5.8 Eff. Depr. Rate (%) 10.7 10.2 10.0 9.7 FCFE / PAT (85.1) 45.9 47.4 63.9 Source: Company Data, PL Research. Balance Sheet Abstract (Rs m) Y/e March 2014 2015 2016E 2017E Shareholder's Funds 91,820 122,489 141,592 165,782 Total Debt 524 6,746 6,746 6,746 Other Liabilities 21,637 18,446 18,446 18,446 Total Liabilities 113,981 147,681 166,784 190,974 Net Fixed Assets 22,966 28,723 34,423 38,406 Goodwill 5,640 17,283 17,283 17,283 Investments 14,719 21,028 21,028 21,028 Net Current Assets 57,532 63,685 77,087 97,295 Cash & Equivalents 33,202 24,049 26,956 39,392 Other Current Assets 69,745 90,436 103,462 119,501 Current Liabilities 45,415 50,800 53,331 61,598 Other Assets 13,124 16,962 16,962 16,962 Total Assets 113,981 147,681 166,784 190,974 Quarterly Financials (Rs m) Y/e March Q1FY15 Q2FY15 Q3FY15 Q4FY15 Net Revenue 51,215 54,879 57,517 61,168 EBITDA 9,284 10,973 11,601 9,286 % of revenue 18.1 20.0 20.2 15.2 Depr. & Amortization 1,492 1,425 1,441 1,721 Net Interest 41 41 38 177 Other Income 893 576 190 (653) Profit before Tax 8,644 10,083 10,312 6,735 Total Tax 2,308 2,807 2,512 1,845 Profit after Tax 6,307 7,196 8,054 4,721 Adj. PAT 6,307 7,196 7,769 4,720 Key Operating Metrics Y/e March 2014 2015 2016E 2017E Volume (persons months) — — — — Realization (US$ / Hr) — — — — Currency (USDINR) 60 61 64 63 SW Devp. Cost (% of Sales) 62.1 67.0 69.9 69.1 SG&A (% of sales) 15.7 14.6 14.5 14.3 Revenue (US$ m) 3,098 3,686 4,087 4,758 EBITDA Margin Expansion/(Erosion) (bps) 84.4 (385.9) (276.5) 98.8 Tax Rate (%) 20 27 26 26 Source: Company Data, PL Research.
  • 4. June 29, 2015 4 Tech Mahindra Prabhudas Lilladher Pvt. Ltd. 3rd Floor, Sadhana House, 570, P. B. Marg, Worli, Mumbai-400 018, India Tel: (91 22) 6632 2222 Fax: (91 22) 6632 2209 Rating Distribution of Research Coverage PL’s Recommendation Nomenclature 42.9% 39.8% 17.3% 0.0% 0% 10% 20% 30% 40% 50% BUY Accumulate Reduce Sell %ofTotalCoverage BUY : Over 15% Outperformance to Sensex over 12-months Accumulate : Outperformance to Sensex over 12-months Reduce : Underperformance to Sensex over 12-months Sell : Over 15% underperformance to Sensex over 12-months Trading Buy : Over 10% absolute upside in 1-month Trading Sell : Over 10% absolute decline in 1-month Not Rated (NR) : No specific call on the stock Under Review (UR) : Rating likely to change shortly DISCLAIMER/DISCLOSURES ANALYST CERTIFICATION We/I, Mr. Shashi Bhusan (BTech (IIT), MBA (IIM)), Mr. Hussain Kagzi (BMS), Research Analysts, authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. Terms & conditions and other disclosures: Prabhudas Lilladher Pvt. Ltd, Mumbai, India (hereinafter referred to as “PL”) is engaged in the business of Stock Broking, Portfolio Manager, Depository Participant and distribution for third party financial products. PL is a subsidiary of Prabhudas Lilladher Advisory Services Pvt Ltd. which has its various subsidiaries engaged in business of commodity broking, investment banking, financial services (margin funding) and distribution of third party financial/other products, details in respect of which are available at www.plindia.com This document has been prepared by the Research Division of PL and is meant for use by the recipient only as information and is not for circulation. This document is not to be reported or copied or made available to others without prior permission of PL. It should not be considered or taken as an offer to sell or a solicitation to buy or sell any security. The information contained in this report has been obtained from sources that are considered to be reliable. However, PL has not independently verified the accuracy or completeness of the same. Neither PL nor any of its affiliates, its directors or its employees accepts any responsibility of whatsoever nature for the information, statements and opinion given, made available or expressed herein or for any omission therein. Recipients of this report should be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The suitability or otherwise of any investments will depend upon the recipient's particular circumstances and, in case of doubt, advice should be sought from an independent expert/advisor. Either PL or its affiliates or its directors or its employees or its representatives or its clients or their relatives may have position(s), make market, act as principal or engage in transactions of securities of companies referred to in this report and they may have used the research material prior to publication. PL may from time to time solicit or perform investment banking or other services for any company mentioned in this document. PL is in the process of applying for certificate of registration as Research Analyst under Securities and Exchange Board of India (Research Analysts) Regulations, 2014 PL submits that no material disciplinary action has been taken on us by any Regulatory Authority impacting Equity Research Analysis activities. PL or its research analysts or its associates or his relatives do not have any financial interest in the subject company. PL or its research analysts or its associates or his relatives do not have actual/beneficial ownership of one per cent or more securities of the subject company at the end of the month immediately preceding the date of publication of the research report. PL or its research analysts or its associates or his relatives do not have any material conflict of interest at the time of publication of the research report. PL or its associates might have received compensation from the subject company in the past twelve months. PL or its associates might have managed or co-managed public offering of securities for the subject company in the past twelve months or mandated by the subject company for any other assignment in the past twelve months. PL or its associates might have received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months. PL or its associates might have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months PL or its associates might have received any compensation or other benefits from the subject company or third party in connection with the research report. PL encourages independence in research report preparation and strives to minimize conflict in preparation of research report. PL or its analysts did not receive any compensation or other benefits from the subject Company or third party in connection with the preparation of the research report. PL or its Research Analysts do not have any material conflict of interest at the time of publication of this report. It is confirmed that Mr. Shashi Bhusan (BTech (IIT), MBA (IIM)), Mr. Hussain Kagzi (BMS), Research Analysts of this report have not received any compensation from the companies mentioned in the report in the preceding twelve months Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. The Research analysts for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report. The research analysts for this report has not served as an officer, director or employee of the subject company PL or its research analysts have not engaged in market making activity for the subject company Our sales people, traders, and other professionals or affiliates may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all o the foregoing, among other things, may give rise to real or potential conflicts of interest. PL and its associates, their directors and employees may (a) from time to time, have a long or short position in, and buy or sell the securities of the subject company or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the subject company or act as an advisor or lender/borrower to the subject company or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. DISCLAIMER/DISCLOSURES (FOR US CLIENTS) ANALYST CERTIFICATION The research analysts, with respect to each issuer and its securities covered by them in this research report, certify that: All of the views expressed in this research report accurately reflect his or her or their personal views about all of the issuers and their securities; and No part of his or her or their compensation was, is or will be directly related to the specific recommendation or views expressed in this research report Terms & conditions and other disclosures: This research report is a product of Prabhudas Lilladher Pvt. Ltd., which is the employer of the research analyst(s) who has prepared the research report. The research analyst(s) preparing the research report is/are resident outside the United States (U.S.) and are not associated persons of any U.S. regulated broker-dealer and therefore the analyst(s) is/are not subject to supervision by a U.S. broker-dealer, and is/are not required to satisfy the regulatory licensing requirements of FINRA or required to otherwise comply with U.S. rules or regulations regarding, among other things, communications with a subject company, public appearances and trading securities held by a research analyst account. This report is intended for distribution by Prabhudas Lilladher Pvt. Ltd. only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the U.S. Securities and Exchange Act, 1934 (the Exchange Act) and interpretations thereof by U.S. Securities and Exchange Commission (SEC) in reliance on Rule 15a 6(a)(2). If the recipient of this report is not a Major Institutional Investor as specified above, then it should not act upon this report and return the same to the sender. Further, this report may not be copied, duplicated and/or transmitted onward to any U.S. person, which is not the Major Institutional Investor. In reliance on the exemption from registration provided by Rule 15a-6 of the Exchange Act and interpretations thereof by the SEC in order to conduct certain business with Major Institutional Investors, Prabhudas Lilladher Pvt. Ltd. has entered into an agreement with a U.S. registered broker-dealer, Marco Polo Securities Inc. ("Marco Polo"). Transactions in securities discussed in this research report should be effected through Marco Polo or another U.S. registered broker dealer.